• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神科医生对首发精神病患者药物治疗期间阳性症状严重程度和日常功能的影响。

Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients.

作者信息

de Beer Franciska, Koops Sanne, Schoevers Robert A, Veling Wim, van Beveren Nico, de Haan Lieuwe, Boonstra Nynke, Kikkert Martijn, Begemann Marieke J H

机构信息

Department of Biomedical Sciences, University of Groningen, University Medical Centre Groningen, Antonius Deusinglaan 1, 9713 AW, Groningen, The Netherlands.

Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

出版信息

Sci Rep. 2024 Oct 2;14(1):22871. doi: 10.1038/s41598-024-72678-4.

DOI:10.1038/s41598-024-72678-4
PMID:39358381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447264/
Abstract

Clinical outcomes after a first-episode of psychosis (FEP) are heterogeneous. Many patient-related factors such as gender and comorbidity have been studied to predict symptomatic outcomes. However, psychiatrist-related factors such as prescription behaviour and gender have received little attention. We assessed the relationship between patients' psychiatrists, psychosis severity and daily functioning in 201 patients remitted from an FEP for a duration of one year, treated by 18 different psychiatrists. We controlled for baseline severity, dose and type of antipsychotic medication, frequency of visits, and patients' education. Symptom severity, daily functioning, and antipsychotic drug use were assessed at baseline and at 3, 6, and, 12 months follow-up. We found that psychiatrists accounted for 9.1% of the explained variance in patients' symptom severity and 10.1% of the explained variance in daily functioning.These effects persisted even when controlling for factors such as baseline severity and the prescribed dose. The effect of prescribed dose on symptom severity and daily functioning differed between psychiatrists. Treatment centre, session frequency, and medication nonadherence were not related to symptom severity. Our results emphasize the importance of individual psychiatrist factors in symptomatic outcomes after an FEP. Further identification of psychiatrist-related factors such as the quality of therapeutic alliances and shared decision-making, may optimize psychiatrists' training with the goal of improving patient outcomes.

摘要

首次发作精神病(FEP)后的临床结局具有异质性。许多与患者相关的因素,如性别和共病情况,已被研究用于预测症状结局。然而,与精神科医生相关的因素,如处方行为和性别,却很少受到关注。我们评估了201例从FEP缓解一年的患者的精神科医生、精神病严重程度和日常功能之间的关系,这些患者由18位不同的精神科医生治疗。我们对基线严重程度、抗精神病药物的剂量和类型、就诊频率以及患者的教育程度进行了控制。在基线以及随访3个月、6个月和12个月时评估症状严重程度、日常功能和抗精神病药物的使用情况。我们发现,精神科医生占患者症状严重程度解释方差的9.1%,占日常功能解释方差的10.1%。即使在控制了基线严重程度和规定剂量等因素后,这些效应仍然存在。规定剂量对症状严重程度和日常功能的影响在不同精神科医生之间存在差异。治疗中心、就诊频率和药物不依从性与症状严重程度无关。我们的结果强调了个体精神科医生因素在FEP后症状结局中的重要性。进一步识别与精神科医生相关的因素,如治疗联盟的质量和共同决策,可能会优化精神科医生的培训,以改善患者结局为目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/83e0f5714aa4/41598_2024_72678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/26b4c6b4ac71/41598_2024_72678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/8cf51816906c/41598_2024_72678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/1fec527aaf0c/41598_2024_72678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/2d010345ef3f/41598_2024_72678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/83e0f5714aa4/41598_2024_72678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/26b4c6b4ac71/41598_2024_72678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/8cf51816906c/41598_2024_72678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/1fec527aaf0c/41598_2024_72678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/2d010345ef3f/41598_2024_72678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b32/11447264/83e0f5714aa4/41598_2024_72678_Fig5_HTML.jpg

相似文献

1
Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients.精神科医生对首发精神病患者药物治疗期间阳性症状严重程度和日常功能的影响。
Sci Rep. 2024 Oct 2;14(1):22871. doi: 10.1038/s41598-024-72678-4.
2
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.继续还是不继续?首发精神病中抗精神病药物维持治疗与剂量减少/停药的比较:HAMLETT,一项实用的多中心单盲随机对照试验。
Trials. 2020 Feb 7;21(1):147. doi: 10.1186/s13063-019-3822-5.
3
Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.精神科医生对缓解期首发精神病停药的看法:亚洲早期精神病网络的多中心研究。
Early Interv Psychiatry. 2019 Dec;13(6):1329-1337. doi: 10.1111/eip.12765. Epub 2018 Nov 28.
4
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.心理干预、抗精神病药物或联合治疗对首发精神病的青少年:MAPS 可行性三臂 RCT。
Health Technol Assess. 2021 Jan;25(4):1-124. doi: 10.3310/hta25040.
5
Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.前驱期阈下精神病症状与首发精神病治疗期间纵向结局的关联。
JAMA Psychiatry. 2019 Jan 1;76(1):61-70. doi: 10.1001/jamapsychiatry.2018.2552.
6
When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?何时开始针对精神病症状进行抗精神病治疗:在前驱期还是精神病首次发作时?
Aust N Z J Psychiatry. 2021 Mar;55(3):314-323. doi: 10.1177/0004867420969810. Epub 2020 Nov 3.
7
Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.二十碳五烯酸乙酯治疗首发精神病:一项随机、安慰剂对照试验
J Clin Psychiatry. 2007 Dec;68(12):1867-75. doi: 10.4088/jcp.v68n1206.
8
Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.未使用抗精神病药物的首发精神病青年患者预后良好的预测因素。
Schizophr Res. 2017 Jul;185:130-136. doi: 10.1016/j.schres.2016.12.029. Epub 2017 Jan 6.
9
The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials.抗精神病药停药或维持治疗对缓解期首发精神病患者康复过程的影响:一项随机对照试验的系统评价和荟萃分析。
Eur Psychiatry. 2024 Jan 22;67(1):e13. doi: 10.1192/j.eurpsy.2024.5.
10
Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.阿立哌唑作为早期干预服务中首发精神病初始治疗选择的疗效和耐受性:一项为期一年的结局研究。
Schizophr Res. 2016 Jul;174(1-3):120-125. doi: 10.1016/j.schres.2016.04.036. Epub 2016 May 4.

本文引用的文献

1
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.临床医生对精神分裂症患者药物治疗指南建议的遵从度与患者精神病症状之间的关系。
Int J Neuropsychopharmacol. 2023 Aug 29;26(8):557-565. doi: 10.1093/ijnp/pyad037.
2
Medicine Is Not Gender-Neutral - She Is Male.医学并非性别中立——它是男性专属的。 (此译文可能与原文表意不符,原文表述有些奇特,正常理解Medicine应是中性概念,这里按字面翻译。)
N Engl J Med. 2022 Mar 31;386(13):1284-1287. doi: 10.1056/NEJMms2116556.
3
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry.
是时候支持在精神病学中广泛实施共同决策了。
JAMA Psychiatry. 2021 Nov 1;78(11):1183-1184. doi: 10.1001/jamapsychiatry.2021.2247.
4
Longitudinal assessments of therapeutic alliance predict work performance in vocational rehabilitation for persons with schizophrenia.纵向评估治疗联盟可预测精神分裂症患者职业康复中的工作表现。
Psychol Psychother. 2021 Dec;94(4):915-928. doi: 10.1111/papt.12346. Epub 2021 Apr 26.
5
Determinants of Therapeutic Alliance With People With Psychotic Disorders: A Systematic Literature Review.治疗精神病患者的治疗联盟的决定因素:系统文献综述。
J Nerv Ment Dis. 2020 Apr;208(4):329-339. doi: 10.1097/NMD.0000000000001125.
6
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.继续还是不继续?首发精神病中抗精神病药物维持治疗与剂量减少/停药的比较:HAMLETT,一项实用的多中心单盲随机对照试验。
Trials. 2020 Feb 7;21(1):147. doi: 10.1186/s13063-019-3822-5.
7
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.抗精神病药物治疗急性精神分裂症的剂量-反应Meta 分析。
Am J Psychiatry. 2020 Apr 1;177(4):342-353. doi: 10.1176/appi.ajp.2019.19010034. Epub 2019 Dec 16.
8
What can clinicians do to improve outcomes across psychiatric treatments: a conceptual review of non-specific components.临床医生可以做些什么来改善精神科治疗的结果:非特异性成分的概念性综述。
Epidemiol Psychiatr Sci. 2019 Aug 15;29:e48. doi: 10.1017/S2045796019000428.
9
The relationship between the therapeutic alliance and client variables in individual treatment for schizophrenia spectrum disorders and early psychosis: Narrative review.个体治疗精神分裂谱系障碍和早期精神病中治疗联盟与患者变量之间的关系:叙事综述。
Clin Psychol Rev. 2019 Jul;71:51-62. doi: 10.1016/j.cpr.2019.05.002. Epub 2019 May 21.
10
Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients.门诊精神分裂症患者的治疗联盟与依从性之间的关联
Clin Psychopharmacol Neurosci. 2019 May 31;17(2):273-278. doi: 10.9758/cpn.2019.17.2.273.